126 related articles for article (PubMed ID: 4962939)
41. Antigenic analysis of L strain cells: a new murine leukemia-associated antigen, "L".
Leclerc JC; Levy JP; Varet B; Oppenheim S; Senik A
Cancer Res; 1970 Jul; 30(7):2073-9. PubMed ID: 4318470
[No Abstract] [Full Text] [Related]
42. Expression of tumor associated antigens by a producer and a nonproducer leukemia induced by Rauscher virus (R-MuLV).
Chang KS; Liu W
Cell Immunol; 1979 Feb; 42(2):373-83. PubMed ID: 427880
[No Abstract] [Full Text] [Related]
43. [Effects of iodoacetamide on cells of Rauscher virus leukemia].
Jasmin C; Piton C; Rosenfeld C
Int J Cancer; 1968 Mar; 3(2):254-9. PubMed ID: 5649160
[No Abstract] [Full Text] [Related]
44. [Decline of the malignancy of a cell strain in mice follwoing chronic infection in vitro by the Rauscher leukemia virus].
Barbieri D; Barski G
Rev Fr Etud Clin Biol; 1968; 13(7):703-6. PubMed ID: 5726635
[No Abstract] [Full Text] [Related]
45. Cell-surface antigens induced by Friend and Rauscher virus complexes and their associated lymphatic leukemia viruses in the rat.
Kuzumaki N; Kobayashi H
Cancer Res; 1975 Jul; 35(7):1718-22. PubMed ID: 1131829
[TBL] [Abstract][Full Text] [Related]
46. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
Longstreth JD; Ihle JN; Hanna MG
Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
[No Abstract] [Full Text] [Related]
47. In vitro assessment of cellular immunity to Rauscher leukemia virus.
Mortensen RF; Ceglowski WS; Friedman H
J Immunol; 1973 Sep; 111(3):657-60. PubMed ID: 4741293
[No Abstract] [Full Text] [Related]
48. Characteristics of a tumor cell line and virus derived from hamster tumors induced by Rauscher leukemia virus-transformed hamster embryo cells.
Rhim JS; Huebner RJ; Ting RC; Wivel N; Vass W
Int J Cancer; 1970 Jan; 5(1):28-38. PubMed ID: 5414741
[No Abstract] [Full Text] [Related]
49. Vaccination with a live retrovirus: the nature of the protective immune response.
Ruprecht RM; Mullaney S; Bernard LD; Gama Sosa MA; Hom RC; Finberg RW
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5558-62. PubMed ID: 2371289
[TBL] [Abstract][Full Text] [Related]
50. DEMONSTRATION OF HUMAN MEASLES ANTIBODY BY MIXED AGGLUTINATION.
BARRON AL; MILGROM F; KARZON DT; WITEBSKY E
J Immunol; 1963 Jun; 90():908-13. PubMed ID: 14050201
[No Abstract] [Full Text] [Related]
51. [Study of group- and type-specific antigens in the process of development of viral murine leukemias].
Gurtsevich VE; Mazurenko NP
Vopr Onkol; 1973; 19(1):66-70. PubMed ID: 4121908
[No Abstract] [Full Text] [Related]
52. [Persistence of Rauscher virus in the body of virus-resistant mice infected with this virus and also in leukemia caused by mixed Mycoplasma-viral infection].
Postnikova ZA; Morgunova TD; Rakovskaia IV; Balashova OI
Vestn Akad Med Nauk SSSR; 1976; (6):88-94. PubMed ID: 997859
[No Abstract] [Full Text] [Related]
53. Antigenic comparison of Rauscher murine leukemia virus cultivated in human embryo and mouse cells.
Traul KA; Mayyasi SA; Garon CE; Schidlovsky G; Bulfone LM
Proc Soc Exp Biol Med; 1972 Jan; 139(1):10-4. PubMed ID: 4621398
[No Abstract] [Full Text] [Related]
54. Separation of the tumor rejection antigen (TSTA) from the major viral structural proteins associated with the membrance of an R-MuLV-induced leukemia.
Rogers MJ; Law LW; Prat M; Oroszlan S; Appella E
Int J Cancer; 1978 Feb; 21(2):246-52. PubMed ID: 627429
[No Abstract] [Full Text] [Related]
55. Nature and complexity of the FMR antigenic system.
Bismuth A; Kremsdorf D; Debré P; Levy JP
Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
[No Abstract] [Full Text] [Related]
56. Leukemia in AKR mice. II. Two modes of suppression of in vitro antibody formation by leukemic cells.
Roman JM; Golub ES
Cell Immunol; 1978 Oct; 40(2):316-25. PubMed ID: 719762
[No Abstract] [Full Text] [Related]
57. Antiserum inactivation of hematopoietic colony forming stem cells from mice with Rauscher leukemia.
Okunewick JP; Phillips EL; Brozovich BJ
Experientia; 1974 Dec; 30(12):1470-1. PubMed ID: 4442558
[No Abstract] [Full Text] [Related]
58. Are the neoantigens induced by leukemogenic viruses particular to cancer cells?
Mathé G
Bibl Haematol; 1968; 30():43-7. PubMed ID: 4877327
[No Abstract] [Full Text] [Related]
59. Macrophage involvement in leukemia virus-induced tumorigenesis.
Bendinelli M; Matteucci D; Toniolo A; Friedman H
Adv Exp Med Biol; 1979; 121B():493-508. PubMed ID: 232621
[No Abstract] [Full Text] [Related]
60. [Mechanism of the modifying effect of neuraminidase of the influenza virus on the development of Rauscher leukemia].
Novichenko NL; Struk VI
Eksp Onkol; 1984; 6(3):29-32. PubMed ID: 6499739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
